Product Reports Resources Pricing Login Book a demo
Stefano Gullà
Person profile

Stefano Gullà

Super founder
1
Companies founded
$473M
Total funding raised
1 school
Education

Companies founded

Currently

Active roles, board seats and partnerships.

Kling Biotherapeutics
CSO · 2023 – present

Work history

Past roles by Dealroom records.

RVAC Medicines
VP · 2022 – 2023
Repertoire Immune Medicines
Director · 2021 – 2022
Agenus
Program Manager, Portfolio Manager · 2015 – 2016
Pfizer
Project Leader · 2010 – 2015
Massachusetts Institute of Technology
Postdoctoral Associate · 2009 – 2010

Education

Massachusetts Institute of Technology
2008 – 2010
← All people